Literature DB >> 11939886

Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.

Mohammed H Moghadasian1, Gerald Salen, Jiri J Frohlich, Charles H Scudamore.   

Abstract

This mini-review deals with a new appraisal of cerebrotendinous xanthomatosis. In addition to neurologic symptoms, patients with cerebrotendinous xanthomatosis develop cataracts, diarrhea, Achilles tendon xanthoma, atherosclerotic vascular disease, and many other abnormalities. Although the pathophysiology of the disease is not completely understood, excess production and consequent accumulation of cholestanol in tissues may play a crucial role. Chenodeoxycholic acid is the most effective therapy. The causative role and detrimental effects (at a low plasma level) of cholestanol merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939886     DOI: 10.1001/archneur.59.4.527

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  25 in total

1.  Cerebrotendinous xanthomatosis: neuropathological findings.

Authors:  B Pilo de la Fuente; I Ruiz; A Lopez de Munain; A Jimenez-Escrig
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

2.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

3.  Cerebrotendinous xanthomatosis presenting with bilateral Achilles tendon xanthomata.

Authors:  Abigail Smithard; Michael J Lamyman; Catherine L McCarthy; C L M H Gibbons; Paul J Cooke; Nicholas Athanasou
Journal:  Skeletal Radiol       Date:  2006-05-20       Impact factor: 2.199

4.  Cerebrotendinous xanthomatosis: a treatable hereditary neuro-metabolic disease.

Authors:  Ana Claudia Rodrigues de Cerqueira; Antônio Egídio Nardi; Jose Marcelo Ferreira Bezerra
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Xanthomatous infiltration of the rotator cuff and long head of biceps with rotator cuff tear in a patient with mixed hyperlipidemia: a case report with MRI imaging.

Authors:  Shelley S Bath; Shaun Bath; Jamshid Tehranzahdeh
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-11-21

Review 6.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

Review 7.  Mechanisms of disease: Inborn errors of bile acid synthesis.

Authors:  Shikha S Sundaram; Kevin E Bove; Mark A Lovell; Ronald J Sokol
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-06-24

8.  Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages.

Authors:  Attila Szanto; Szilvia Benko; Istvan Szatmari; Balint L Balint; Ibolya Furtos; Ralph Rühl; Sandor Molnar; Laszlo Csiba; Rita Garuti; Sebastiano Calandra; Hanna Larsson; Ulf Diczfalusy; Laszlo Nagy
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 9.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

Review 10.  Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).

Authors:  Gerald Salen; Robert D Steiner
Journal:  J Inherit Metab Dis       Date:  2017-10-04       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.